More than 100 factories in India are central to U.S. drug making vital ingredients. Totally, they are the basic layer on how America’s giant drug supply chain is made. U.S. Pharmacopeia (USP), the biggest industry, has a critical role in providing chemical samples for quality. Indian factories provide vast amounts of ingredients for generic drugs in America.
The Food and Drug Administration (FDA) found that India is central to ingredient production. Ron Piervincenzi, USP Chief Executive Officer agreed with the data, India is leading the huge supply chain. Active ingredients provided in India are effective drugs against disease or condition.
Previously, the company struggled with the Indian government due to certain drug export bans. During the surge of pandemic, the government of India cut off supplies of certain drugs to protect domestic stock. The active ingredients in Tylenol, antibiotics, and acetaminophen are under the country’s protection. It is actually vital to maintain sufficient domestic needs.
However, due to the current Russian invasion of Ukraine, Russia received no condemnation from India. India continues trading with Russia, even avoids criticizing Mr. Putin. The Biden administration warned U.S. pharmaceutical companies about durg supplies from India. They attempt to lessen the dependence for drug commodities.
India is central to global active ingredient manufacturing plants for generic drugs. More than 90% of the drugs are what America takes. It is inevitable not to rely on India. Moreover, out of 100 drugs, 83 of them are not from America. Besides the shortages of drug dependence in India, the transportation cost is another challenge. According to the Association of Accessible Medicines, the cargo costs increased to 227% since the pandemic. Worse, during the invasion, ocean cargo increased to 193%. This number can still go up as oil and gas prices are skyrocketing.
